Accelerating Vaccine Development and Manufacturing

The use of approved platform technologies can reduce the time and cost required to generate new vaccines.

Established vaccine manufacturing technologies are complex, often highly customized, and typically require dedicated facilities. Development and approval times can be lengthy, presenting hurdles for medical professionals seeking rapid response to pandemic diseases.

Standardized vaccine manufacturing platforms that can be deployed across different vaccines and vaccine types, could speed the delivery of vaccines and enable manufacturing in emerging economies. Technical and funding challenges must be overcome to bring the advanced manufacturing potential to reality.

Download

Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017

eBook.

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 11–19

Citation

When referring to this article, please cite it as C Challener, " Accelerating Vaccine Development and Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

Articles in this issue

almost 8 years ago

Article

Designing and Operating Flexible, High-Containment Vaccine Manufacturing

almost 8 years ago

Article

Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases

almost 8 years ago

Article

Cold Chain: Delivering Vaccines to Patients

almost 8 years ago

Article

Using Human Challenge Trials to Develop Flu Vaccines

almost 8 years ago

Article

Moving to Closed Systems for Aseptic Processing

almost 8 years ago

Article

Making Vaccines Accessible

almost 8 years ago

Article

Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!